Edgar Selem, Mikolaj Raszek, Joseph Varon, Matthew Halma
{"title":"The persistence of COVID-19 vaccine artifacts in bodily fluids and tissues: a systematic review","authors":"Edgar Selem, Mikolaj Raszek, Joseph Varon, Matthew Halma","doi":"10.1186/s43094-026-00939-2","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Early assumptions about COVID-19 vaccine components suggested that modified messenger RNA and spike protein would be rapidly cleared from the body, consistent with the known degradation pathways of natural RNA. However, multiple studies have identified these vaccine-derived components in human tissues and bodily fluids for unexpectedly prolonged periods after vaccination. This persistence challenges initial expectations and raises important questions about the mechanisms enabling such long-term presence.</p><h3>Main body</h3><p>This review systematically examines the evidence for enduring COVID-19 vaccine components, including modified messenger RNA, spike protein, and lipid nanoparticles, in the human body long after administration. We evaluate the techniques used to detect these substances, highlighting the sensitivity and specificity of various assays, and summarize the specific tissues and fluids where these components have been found. Special attention is given to methodological considerations that may influence detection and interpretation. Furthermore, this review explores potential biological explanations for the prolonged presence of vaccine-derived material. Possible mechanisms include altered RNA stability due to chemical modifications, slow clearance of lipid nanoparticles, and the formation of stable complexes or reservoirs within tissues. The evidence for each hypothesis is discussed, with an emphasis on distinguishing between true persistence and assay artifacts.</p><h3>Conclusion</h3><p>The reported persistence of COVID-19 vaccine components in the body is a phenomenon that warrants deeper investigation. While methodological factors must be carefully considered, the available data suggest that certain vaccine derivatives may remain detectable for extended periods. Understanding the underlying mechanisms is important for assessing vaccine safety and optimizing future mRNA-based therapeutics.</p><h3>Graphic abstract</h3><p>Figure adapted Halma MTJ, Rose J, Lawrie T (2023) The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review. J 6:220–235. https://doi.org/10.3390/j6020017 under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).</p>\n<div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":577,"journal":{"name":"Future Journal of Pharmaceutical Sciences","volume":"12 1","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2026-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1186/s43094-026-00939-2.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1186/s43094-026-00939-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Early assumptions about COVID-19 vaccine components suggested that modified messenger RNA and spike protein would be rapidly cleared from the body, consistent with the known degradation pathways of natural RNA. However, multiple studies have identified these vaccine-derived components in human tissues and bodily fluids for unexpectedly prolonged periods after vaccination. This persistence challenges initial expectations and raises important questions about the mechanisms enabling such long-term presence.
Main body
This review systematically examines the evidence for enduring COVID-19 vaccine components, including modified messenger RNA, spike protein, and lipid nanoparticles, in the human body long after administration. We evaluate the techniques used to detect these substances, highlighting the sensitivity and specificity of various assays, and summarize the specific tissues and fluids where these components have been found. Special attention is given to methodological considerations that may influence detection and interpretation. Furthermore, this review explores potential biological explanations for the prolonged presence of vaccine-derived material. Possible mechanisms include altered RNA stability due to chemical modifications, slow clearance of lipid nanoparticles, and the formation of stable complexes or reservoirs within tissues. The evidence for each hypothesis is discussed, with an emphasis on distinguishing between true persistence and assay artifacts.
Conclusion
The reported persistence of COVID-19 vaccine components in the body is a phenomenon that warrants deeper investigation. While methodological factors must be carefully considered, the available data suggest that certain vaccine derivatives may remain detectable for extended periods. Understanding the underlying mechanisms is important for assessing vaccine safety and optimizing future mRNA-based therapeutics.
Graphic abstract
Figure adapted Halma MTJ, Rose J, Lawrie T (2023) The Novelty of mRNA Viral Vaccines and Potential Harms: A Scoping Review. J 6:220–235. https://doi.org/10.3390/j6020017 under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
期刊介绍:
Future Journal of Pharmaceutical Sciences (FJPS) is the official journal of the Future University in Egypt. It is a peer-reviewed, open access journal which publishes original research articles, review articles and case studies on all aspects of pharmaceutical sciences and technologies, pharmacy practice and related clinical aspects, and pharmacy education. The journal publishes articles covering developments in drug absorption and metabolism, pharmacokinetics and dynamics, drug delivery systems, drug targeting and nano-technology. It also covers development of new systems, methods and techniques in pharmacy education and practice. The scope of the journal also extends to cover advancements in toxicology, cell and molecular biology, biomedical research, clinical and pharmaceutical microbiology, pharmaceutical biotechnology, medicinal chemistry, phytochemistry and nutraceuticals.